Copyright
©2011 Baishideng Publishing Group Co.
World J Clin Oncol. Jun 10, 2011; 2(6): 272-280
Published online Jun 10, 2011. doi: 10.5306/wjco.v2.i6.272
Published online Jun 10, 2011. doi: 10.5306/wjco.v2.i6.272
Study | n | High levels of CD105 were associated with | High levels of VEGF were associated with |
Barozzi et al[7] | 101 | M1 | M1 |
Saad et al[25] | 150 | M1, N1 and angiolymphatic invasion | N1, angiolymphatic and depth of invasion |
De Vita et al [37] | 81 | NE | NCs (serum levels) |
Cascinu et al[38] | 121 | NE | RR |
Myśliwiec et al[29] | 48 | M1 | Colorectal cancer patients (plasma levels) |
Li et al[48] | 111 | Dukes' stages and survival | NE |
Takahashi et al[49] | 34 | M1 | NE |
Liang et al[51] | 114 | NE | N1, TNM staging and poor prognosis |
Zheng et al[52] | 97 | NE | Poorly differentiated adenocarcinoma |
Cressey et al [31] | 76 | NE | TNM |
Cao et al[53] | 71 | NE | N1, M1, TNM, and OS |
Miyazaki et al[58] | 127 | NE | RR, DF, OS (plasma levels) |
- Citation: Martins SF, Reis RM, Rodrigues AM, Baltazar F, Filho AL. Role of endoglin and VEGF family expression in colorectal cancer prognosis and anti-angiogenic therapies. World J Clin Oncol 2011; 2(6): 272-280
- URL: https://www.wjgnet.com/2218-4333/full/v2/i6/272.htm
- DOI: https://dx.doi.org/10.5306/wjco.v2.i6.272